Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-017913
Filing Date
2025-06-20
Accepted
2025-06-20 20:20:38
Documents
1
Period of Report
2025-06-16

Document Format Files

Seq Description Document Type Size
1 form4-06212025_120634.html 4  
1 form4-06212025_120634.xml 4 3834
  Complete submission text file 0001415889-25-017913.txt   5350
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Issuer) CIK: 0001496323 (see all company filings)

EIN.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O IGM IOSCIENCES, INC. 325 E,. MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94063
Business Address
Harler Mary Beth (Reporting) CIK: 0002018699 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39045 | Film No.: 251062732